![]() | Up a level |
Abolmaali, M. and Heidari, M. and Zeinali, M. and Moghaddam, P. and Ramezani Ghamsari, M. and Jamshidi Makiani, M. and Mirzaasgari, Z. (2021) Guillain�Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series. Journal of Clinical Neuroscience, 83. pp. 119-122.
Esmaeili, S. and Abbasi, M.H. and Abolmaali, M. and Mojtahed, M. and Alavi, S.N.R. and Soleimani, S. and Mokhtari, M. and Hatam, J. and Khotbehsara, S.T. and Motamed, M.R. and Joghataei, M.T. and Mirzaasgari, Z. and Moghaddasi, M. (2021) Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD. BMC Neurology, 21 (1).
Esmaeili, S. and Abolmaali, M. and Aarabi, S. and Motamed, M.R. and Chaibakhsh, S. and Joghataei, M.T. and Mojtahed, M. and Mirzaasgari, Z. (2021) Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurology, 21 (1).
Hasani, H. and Es�haghi, A. and Rafatnia, S. and Alilou, S. and Abolmaali, M. (2020) Keratopigmentation: a comprehensive review. Eye (Basingstoke), 34 (6). pp. 1039-1046.